title: Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children's Oncology Group report.
authors.forename: S
authors.initials: S
authors.lastname: Goldman
authors.forename: L
authors.initials: L
authors.lastname: Smith
authors.forename: J R
authors.initials: JR
authors.lastname: Anderson
authors.forename: S
authors.initials: S
authors.lastname: Perkins
authors.forename: L
authors.initials: L
authors.lastname: Harrison
authors.forename: M B
authors.initials: MB
authors.lastname: Geyer
authors.forename: T G
authors.initials: TG
authors.lastname: Gross
authors.forename: H
authors.initials: H
authors.lastname: Weinstein
authors.forename: S
authors.initials: S
authors.lastname: Bergeron
authors.forename: B
authors.initials: B
authors.lastname: Shiramizu
authors.forename: W
authors.initials: W
authors.lastname: Sanger
authors.forename: M
authors.initials: M
authors.lastname: Barth
authors.forename: J
authors.initials: J
authors.lastname: Zhi
authors.forename: M S
authors.initials: MS
authors.lastname: Cairo
mesh_terms: D000293:Adolescent; D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007223:Infant; D016393:Lymphoma, B-Cell / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D009367:Neoplasm Staging; D011241:Prednisone / Q000008:administration & dosage; D000069283:Rituximab; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone; D008727:Methotrexate